Searched for
NUTRACEUTICALS INDUSTRY
NDude Labs invests in nutraceutical ingredients firm NutriventiaThe investment will help Nutriventia strengthen its research and development pipeline, expand its global commercial presence and scale its ...- From Mamaearth to Phool: Shilpa Shetty, MS Dhoni, Sachin Tendulkar, Alia Bhatt among celebrity investors to back startupsCelebrity investments: Bollywood stars and cricket legends are increasingly backing Indian startups. A Tracxn report identifies 10 celebrit...
- Shilpa Shetty beats Virat Kohli, MS Dhoni: 10 celebrities with the highest number of startup investment roundsShilpa Shetty Kundra leads Tracxn’s ranking of celebrity startup investors with 10 disclosed funding rounds between 2021 and 2026 YTD. MS D...
- Symbiotec Pharmalab shares list at 1% discount to IPO priceThe Symbiotec Pharmalab IPO plans to channel Rs 112.50 crore towards the prepayment and/or repayment, fully or partially, of select outstan...
- Symbiotec Pharmalab IPO Day 4: GMP at 29%, subscription reaches 5.31xSymbiotec Pharmalab's IPO saw strong investor demand, closing oversubscribed 71.26 times. The company aimed to raise Rs 1,757 crore through...
- Plant-based protein market poised to reach Rs 9,000 cr in five years: Industry body PBFIAIndia's plant-based protein ingredient market is set to double to Rs 9,000 crore within five years. Consumers are shifting towards targeted...
- Symbiotec Pharmalab IPO Day 2: GMP signals 34% upside — Should you subscribe?Symbiotec Pharmalab's IPO saw robust investor demand, with the issue subscribed 1.85 times. The company aims to raise Rs 1,757 crore throug...
- Boost for Ladakh: High-level panel to plan national sea buckthorn research hubA high-level committee will examine establishing a National Sanjeevani Research Centre for Sea Buckthorn. This initiative aims to position ...
- Symbiotec Pharmalab’s Rs 1,757 crore IPO opens with GMP hinting at 41% upside. Should you bid?Symbiotec Pharmalab IPO GMP: Symbiotec Pharmalab’s Rs 1,757 crore IPO opened August 24, with a Rs 938–988 price band and 41% grey-market pr...
- Kronox Lab Sciences shares rally 32% in 2 days as Indo Borax, Zenrock Chemicals eye stake acquisitionShares of Kronox Lab Sciences surged after Indo Borax and Zenrock Chemicals announced plans to acquire a 64.26% stake in the company and la...
- Symbiotec Pharmalab sets price band for Rs 1,757 crore IPO, to open on August 24Symbiotec Pharmalab will launch its ₹1,757-crore IPO from August 24–27, 2026, with a price band of ₹938–988 per share. The minimum bid is 1...
- Chemical sector: Although long, there is a way around China trouble; combine 20 stocks to get your portfolio’s chemistry rightFor the chemicals sector, it all depends on a transformation that is still unfolding and will take years to play out. Backward-integration ...
- Picking the right pharma stock is getting harder; so pick a portfolio: 20 stocks with -23% to +22% downside to upside potentialFor Indian pharma, the regulatory risk is still real. A US FDA inspection can still cause trouble. A plant making an important product or g...
- Warburg set to buy Seacod-maker Universal NutriScience for Rs 2800 croreWill be 4th acquisition for the US private equity giant in India’s healthsector in four months. Kedaara to make 5x rupee returns on exit.
- The ethanol story is changing. Is investing in the ecosystem the better way? 15 stocks across different market cap segmentsThe ethanol story started simply enough: Cut India's dependence on imported crude oil. It would save foreign exchange. Give farmers a new a...
- Tariff on generic drugs: Loud announcement, little consequence? 7 pharma stocks with upside potential of up to 31%The threat of a US tariff on Indian pharma is no longer a vague fear; or at least that is what President Trump wants us to believe. There i...
- Bain Capital in advanced talks for 25% stake in IndusInd Insurance, marking its first India insurance betBain Capital is nearing a deal to buy a significant stake in IndusInd General Insurance. This acquisition could value the insurer at over s...
- Cabinet approves Rs 3,030 crore Bhavya Rasayan Scheme for three chemical parksWith a financial commitment of Rs 3,030 crore, the Union Cabinet has approved the Bhavya Rasayan Scheme. This forward-thinking initiative w...
- Risk is integral to the market; but there are different kinds of risk: 6 mid-cap stocks with upside potential of up to 21%We are in uncertain and volatile times. Does that mean investors should just sit out the downturn? While that is an option, the better opti...
- FSSAI crackdown serves food for thought as packaged food makers seek clearer rulesIn a bid to strengthen consumer protection, India's food regulatory body is intensifying efforts against packaged food companies. The lack ...
Load More
